Lovenox vs Pradaxa
Side-by-side cost comparison based on Medicare Part D data
Lovenox
Enoxaparin
Manufactured by Sanofi
Pradaxa
Dabigatran
Manufactured by Boehringer Ingelheim
Lovenox costs 48% less per claim than Pradaxa ($94.00 vs $180.00). A generic version of Lovenox is also available, which may reduce costs further.
Cost Per Claim
Medicare Spending
Beneficiaries
Annual Cost Per Patient
Full Comparison
| Metric | Lovenox | Pradaxa |
|---|---|---|
| Avg Cost Per Claim | $94.00 | $180.00 |
| Total Medicare Spending | $456.0M | $876.0M |
| Total Beneficiaries | 580,000 | 580,000 |
| Total Claims | 4,860,000 | 4,860,000 |
| Annual Cost/Patient | $786.00 | $1,510.00 |
| Year-over-Year Change | -14.2% | -9.8% |
| Generic Available | Yes | Yes |
| Patent Expiration | Jan 31, 2023 | Jan 31, 2023 |
| Manufacturer | Sanofi | Boehringer Ingelheim |
| Condition | Blood Clots | Blood Clots |
| Generic Name | Enoxaparin | Dabigatran |
Lovenox vs Pradaxa: What the Data Shows
Lovenox (Enoxaparin) and Pradaxa (Dabigatran) are both used to treat blood clots. Based on Medicare Part D data, Lovenox costs $94.00 per claim, which is 48% less than Pradaxa at $180.00 per claim.
Medicare spent $456.0M on Lovenox and $876.0M on Pradaxa. In terms of patient reach, Pradaxa serves more beneficiaries (580,000 vs 580,000).
Year-over-year spending changed -14.2% for Lovenox and -9.8% for Pradaxa.
Both drugs have generic versions available. Patients should discuss generic alternatives with their pharmacist to reduce out-of-pocket costs.
Frequently Asked Questions
Lovenox is cheaper at $94.00 per claim, compared to $180.00 for Pradaxa. That makes Lovenox about 48% less expensive per claim based on Medicare Part D data.
Yes, both Lovenox and Pradaxa are used to treat blood clots. Your doctor can help determine which medication is more appropriate for your specific situation.
Both drugs have generic versions available. Generic Enoxaparin and generic Dabigatran can offer significant cost savings — typically 80-95% less than the brand name.
Medicare Part D spent $456.0M on Lovenox covering 580,000 beneficiaries, and $876.0M on Pradaxa covering 580,000 beneficiaries.
Explore Further
Cost data reflects Medicare Part D spending and may not represent retail pharmacy prices. Average cost per claim represents the total drug cost (not patient out-of-pocket) divided by total claims. This comparison is informational only and should not replace medical advice.